Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma

Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node–involved penile squamous-cell carcinoma (PSCC) are lacking. To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology oncology 2021-10, Vol.4 (5), p.802-810
Hauptverfasser: Bandini, Marco, Ross, Jeffrey S., Zhu, Yao, Ye, Ding-Wei, Ornellas, Antonio A., Watkin, Nick, Ayres, Benjamin A., Hakenberg, Oliver W., Heidenreich, Axel, Salvioni, Roberto, Catanzaro, Mario, Raggi, Daniele, Giannatempo, Patrizia, Marandino, Laura, Haidl, Friederike, Pederzoli, Filippo, Briganti, Alberto, Montorsi, Francesco, Chipollini, Juan, Azizi, Mounsif, De Meerleer, Gert, Brouwer, Oscar R., Grass, G. Daniel, Johnstone, Peter A., Albersen, Maarten, Spiess, Philippe E., Necchi, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 810
container_issue 5
container_start_page 802
container_title European urology oncology
container_volume 4
creator Bandini, Marco
Ross, Jeffrey S.
Zhu, Yao
Ye, Ding-Wei
Ornellas, Antonio A.
Watkin, Nick
Ayres, Benjamin A.
Hakenberg, Oliver W.
Heidenreich, Axel
Salvioni, Roberto
Catanzaro, Mario
Raggi, Daniele
Giannatempo, Patrizia
Marandino, Laura
Haidl, Friederike
Pederzoli, Filippo
Briganti, Alberto
Montorsi, Francesco
Chipollini, Juan
Azizi, Mounsif
De Meerleer, Gert
Brouwer, Oscar R.
Grass, G. Daniel
Johnstone, Peter A.
Albersen, Maarten
Spiess, Philippe E.
Necchi, Andrea
description Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node–involved penile squamous-cell carcinoma (PSCC) are lacking. To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinical information. ILND, with or without chemotherapy or RT for involved lymph nodes. Kaplan-Meier and restricted mean survival time (RMST) analyses for overall survival (OS) were performed for all patients and after propensity score-matching (PSM; n = 136), for which patient age, histology, type of penile surgical procedure, pathological tumor and nodal stage, ILND laterality, pelvic LND, and perioperative treatment were taken into account when assessing differences between HPV+ and HPV– patients. Finally, we looked at genomic alterations in PSCC using data from the Foundation Medicine database (n = 199) to characterize HPV+ PSCC. Patients with HPV+ PSCC (n = 86; 17%) had lower clinical N stage (p < 0.001) and inguinal lymph node metastasis density (p < 0.001). Perioperative RT was delivered in 49 patients (9.7%), with the vast majority receiving adjuvant RT (n = 40). HPV+ patients had similar median OS (p = 0.1) but longer RMST than HPV– patients at different time points. Nevertheless, HPV+ patients treated with perioperative RT exhibited longer median OS (p = 0.015) and longer RMST compared to HPV– patients. In the PSM cohorts, HPV+ status remained significantly associated with longer OS after RT. The HPV– PSCC group had a higher frequency of TP53 mutations compared to HPV+ PSCC (75% vs 15%; p < 0.001). The results are limited by the retrospective nature of the data. Perioperative RT was more effective in the HPV+ PSCC subgroup. Reasons for the enhanced radiosensitivity may be related to the lack of TP53 mutations. We analyzed data from a large multicenter database for patients with penile cancer who had received inguinal lymph node dissection, with or without chemotherapy or radiotherapy. We found that for tumors positive for human papillomavirus (HPV), use of radiotherapy resulted in prolonged survival compared to HPV-negative tumors. On the basis of these results we are inspired to design studies on the use of radiotherapy in HPV-selected patients. We analyzed the association between human papillomavirus (HPV) infecti
doi_str_mv 10.1016/j.euo.2020.10.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2461401167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2588931120301760</els_id><sourcerecordid>2461401167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-1353a94e0634d2fa7a26dee7bf8178d4d0cf93f3a0921d588c8ad50575d6462a3</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhq2qqETAD-il8rGXBH_sp3qiUYFIESAEZ2tij1VHu_bW3g3i39dLaNVTTx6PnveV5iHkM2crznh1uV_hFFaCifm_Ypx_IAtRNs2ylZx__Gc-JRcp7RljM8uZ-EROpeRtK0qxIC9XKQXtYHTB0-84viB6ejv14OkDDK7rQg8HF6dEN96ifsPAG3o_jTr0SIOlDxhdGDDmjgPSu2Cgo49gXBh_5uXwSm2IGfKuQ7qGqJ3PnefkxEKX8OL9PSPP1z-e1rfL7f3NZn21XWrZVuOSy1JCWyCrZGGEhRpEZRDrnW143ZjCMG1baSWwVnCTL9YNmJKVdWmqohIgz8jXY-8Qw68J06h6lzR2HXgMU1KiqHiR5VV1RvkR1TGkFNGqIboe4qviTM3K1V5l5WrWOK9yKme-vNdPux7N38QfwRn4dgQwH3lwGFXSDr1G42LWqUxw_6n_Da4hkpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2461401167</pqid></control><display><type>article</type><title>Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Bandini, Marco ; Ross, Jeffrey S. ; Zhu, Yao ; Ye, Ding-Wei ; Ornellas, Antonio A. ; Watkin, Nick ; Ayres, Benjamin A. ; Hakenberg, Oliver W. ; Heidenreich, Axel ; Salvioni, Roberto ; Catanzaro, Mario ; Raggi, Daniele ; Giannatempo, Patrizia ; Marandino, Laura ; Haidl, Friederike ; Pederzoli, Filippo ; Briganti, Alberto ; Montorsi, Francesco ; Chipollini, Juan ; Azizi, Mounsif ; De Meerleer, Gert ; Brouwer, Oscar R. ; Grass, G. Daniel ; Johnstone, Peter A. ; Albersen, Maarten ; Spiess, Philippe E. ; Necchi, Andrea</creator><creatorcontrib>Bandini, Marco ; Ross, Jeffrey S. ; Zhu, Yao ; Ye, Ding-Wei ; Ornellas, Antonio A. ; Watkin, Nick ; Ayres, Benjamin A. ; Hakenberg, Oliver W. ; Heidenreich, Axel ; Salvioni, Roberto ; Catanzaro, Mario ; Raggi, Daniele ; Giannatempo, Patrizia ; Marandino, Laura ; Haidl, Friederike ; Pederzoli, Filippo ; Briganti, Alberto ; Montorsi, Francesco ; Chipollini, Juan ; Azizi, Mounsif ; De Meerleer, Gert ; Brouwer, Oscar R. ; Grass, G. Daniel ; Johnstone, Peter A. ; Albersen, Maarten ; Spiess, Philippe E. ; Necchi, Andrea</creatorcontrib><description>Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node–involved penile squamous-cell carcinoma (PSCC) are lacking. To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinical information. ILND, with or without chemotherapy or RT for involved lymph nodes. Kaplan-Meier and restricted mean survival time (RMST) analyses for overall survival (OS) were performed for all patients and after propensity score-matching (PSM; n = 136), for which patient age, histology, type of penile surgical procedure, pathological tumor and nodal stage, ILND laterality, pelvic LND, and perioperative treatment were taken into account when assessing differences between HPV+ and HPV– patients. Finally, we looked at genomic alterations in PSCC using data from the Foundation Medicine database (n = 199) to characterize HPV+ PSCC. Patients with HPV+ PSCC (n = 86; 17%) had lower clinical N stage (p &lt; 0.001) and inguinal lymph node metastasis density (p &lt; 0.001). Perioperative RT was delivered in 49 patients (9.7%), with the vast majority receiving adjuvant RT (n = 40). HPV+ patients had similar median OS (p = 0.1) but longer RMST than HPV– patients at different time points. Nevertheless, HPV+ patients treated with perioperative RT exhibited longer median OS (p = 0.015) and longer RMST compared to HPV– patients. In the PSM cohorts, HPV+ status remained significantly associated with longer OS after RT. The HPV– PSCC group had a higher frequency of TP53 mutations compared to HPV+ PSCC (75% vs 15%; p &lt; 0.001). The results are limited by the retrospective nature of the data. Perioperative RT was more effective in the HPV+ PSCC subgroup. Reasons for the enhanced radiosensitivity may be related to the lack of TP53 mutations. We analyzed data from a large multicenter database for patients with penile cancer who had received inguinal lymph node dissection, with or without chemotherapy or radiotherapy. We found that for tumors positive for human papillomavirus (HPV), use of radiotherapy resulted in prolonged survival compared to HPV-negative tumors. On the basis of these results we are inspired to design studies on the use of radiotherapy in HPV-selected patients. We analyzed the association between human papillomavirus (HPV) infection and perioperative treatment outcomes for patients with penile squamous-cell carcinoma undergoing inguinal lymph node dissection. HPV was associated with greater benefit from perioperative radiotherapy of involved lymph nodes. A Foundation Medicine database analysis of genomic alterations in penile cancers revealed fewer TP53 and CDKN2A mutations for HPV+ than for HPV– tumors, which may in part explain their radiosensitivity.</description><identifier>ISSN: 2588-9311</identifier><identifier>EISSN: 2588-9311</identifier><identifier>DOI: 10.1016/j.euo.2020.10.011</identifier><identifier>PMID: 33199252</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvant radiotherapy ; Carcinoma, Squamous Cell - radiotherapy ; Carcinoma, Squamous Cell - surgery ; Comprehensive genomic profiling ; Human papillomavirus infection ; Humans ; Lymph Node Excision ; Male ; Papillomavirus Infections - complications ; Penile cancer ; Penile Neoplasms - radiotherapy ; Penile Neoplasms - surgery ; Retrospective Studies ; Squamous-cell carcinoma</subject><ispartof>European urology oncology, 2021-10, Vol.4 (5), p.802-810</ispartof><rights>2020 European Association of Urology</rights><rights>Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-1353a94e0634d2fa7a26dee7bf8178d4d0cf93f3a0921d588c8ad50575d6462a3</citedby><cites>FETCH-LOGICAL-c396t-1353a94e0634d2fa7a26dee7bf8178d4d0cf93f3a0921d588c8ad50575d6462a3</cites><orcidid>0000-0002-3007-2756</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33199252$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bandini, Marco</creatorcontrib><creatorcontrib>Ross, Jeffrey S.</creatorcontrib><creatorcontrib>Zhu, Yao</creatorcontrib><creatorcontrib>Ye, Ding-Wei</creatorcontrib><creatorcontrib>Ornellas, Antonio A.</creatorcontrib><creatorcontrib>Watkin, Nick</creatorcontrib><creatorcontrib>Ayres, Benjamin A.</creatorcontrib><creatorcontrib>Hakenberg, Oliver W.</creatorcontrib><creatorcontrib>Heidenreich, Axel</creatorcontrib><creatorcontrib>Salvioni, Roberto</creatorcontrib><creatorcontrib>Catanzaro, Mario</creatorcontrib><creatorcontrib>Raggi, Daniele</creatorcontrib><creatorcontrib>Giannatempo, Patrizia</creatorcontrib><creatorcontrib>Marandino, Laura</creatorcontrib><creatorcontrib>Haidl, Friederike</creatorcontrib><creatorcontrib>Pederzoli, Filippo</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Chipollini, Juan</creatorcontrib><creatorcontrib>Azizi, Mounsif</creatorcontrib><creatorcontrib>De Meerleer, Gert</creatorcontrib><creatorcontrib>Brouwer, Oscar R.</creatorcontrib><creatorcontrib>Grass, G. Daniel</creatorcontrib><creatorcontrib>Johnstone, Peter A.</creatorcontrib><creatorcontrib>Albersen, Maarten</creatorcontrib><creatorcontrib>Spiess, Philippe E.</creatorcontrib><creatorcontrib>Necchi, Andrea</creatorcontrib><title>Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma</title><title>European urology oncology</title><addtitle>Eur Urol Oncol</addtitle><description>Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node–involved penile squamous-cell carcinoma (PSCC) are lacking. To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinical information. ILND, with or without chemotherapy or RT for involved lymph nodes. Kaplan-Meier and restricted mean survival time (RMST) analyses for overall survival (OS) were performed for all patients and after propensity score-matching (PSM; n = 136), for which patient age, histology, type of penile surgical procedure, pathological tumor and nodal stage, ILND laterality, pelvic LND, and perioperative treatment were taken into account when assessing differences between HPV+ and HPV– patients. Finally, we looked at genomic alterations in PSCC using data from the Foundation Medicine database (n = 199) to characterize HPV+ PSCC. Patients with HPV+ PSCC (n = 86; 17%) had lower clinical N stage (p &lt; 0.001) and inguinal lymph node metastasis density (p &lt; 0.001). Perioperative RT was delivered in 49 patients (9.7%), with the vast majority receiving adjuvant RT (n = 40). HPV+ patients had similar median OS (p = 0.1) but longer RMST than HPV– patients at different time points. Nevertheless, HPV+ patients treated with perioperative RT exhibited longer median OS (p = 0.015) and longer RMST compared to HPV– patients. In the PSM cohorts, HPV+ status remained significantly associated with longer OS after RT. The HPV– PSCC group had a higher frequency of TP53 mutations compared to HPV+ PSCC (75% vs 15%; p &lt; 0.001). The results are limited by the retrospective nature of the data. Perioperative RT was more effective in the HPV+ PSCC subgroup. Reasons for the enhanced radiosensitivity may be related to the lack of TP53 mutations. We analyzed data from a large multicenter database for patients with penile cancer who had received inguinal lymph node dissection, with or without chemotherapy or radiotherapy. We found that for tumors positive for human papillomavirus (HPV), use of radiotherapy resulted in prolonged survival compared to HPV-negative tumors. On the basis of these results we are inspired to design studies on the use of radiotherapy in HPV-selected patients. We analyzed the association between human papillomavirus (HPV) infection and perioperative treatment outcomes for patients with penile squamous-cell carcinoma undergoing inguinal lymph node dissection. HPV was associated with greater benefit from perioperative radiotherapy of involved lymph nodes. A Foundation Medicine database analysis of genomic alterations in penile cancers revealed fewer TP53 and CDKN2A mutations for HPV+ than for HPV– tumors, which may in part explain their radiosensitivity.</description><subject>Adjuvant radiotherapy</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Comprehensive genomic profiling</subject><subject>Human papillomavirus infection</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Male</subject><subject>Papillomavirus Infections - complications</subject><subject>Penile cancer</subject><subject>Penile Neoplasms - radiotherapy</subject><subject>Penile Neoplasms - surgery</subject><subject>Retrospective Studies</subject><subject>Squamous-cell carcinoma</subject><issn>2588-9311</issn><issn>2588-9311</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PGzEQhq2qqETAD-il8rGXBH_sp3qiUYFIESAEZ2tij1VHu_bW3g3i39dLaNVTTx6PnveV5iHkM2crznh1uV_hFFaCifm_Ypx_IAtRNs2ylZx__Gc-JRcp7RljM8uZ-EROpeRtK0qxIC9XKQXtYHTB0-84viB6ejv14OkDDK7rQg8HF6dEN96ifsPAG3o_jTr0SIOlDxhdGDDmjgPSu2Cgo49gXBh_5uXwSm2IGfKuQ7qGqJ3PnefkxEKX8OL9PSPP1z-e1rfL7f3NZn21XWrZVuOSy1JCWyCrZGGEhRpEZRDrnW143ZjCMG1baSWwVnCTL9YNmJKVdWmqohIgz8jXY-8Qw68J06h6lzR2HXgMU1KiqHiR5VV1RvkR1TGkFNGqIboe4qviTM3K1V5l5WrWOK9yKme-vNdPux7N38QfwRn4dgQwH3lwGFXSDr1G42LWqUxw_6n_Da4hkpg</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Bandini, Marco</creator><creator>Ross, Jeffrey S.</creator><creator>Zhu, Yao</creator><creator>Ye, Ding-Wei</creator><creator>Ornellas, Antonio A.</creator><creator>Watkin, Nick</creator><creator>Ayres, Benjamin A.</creator><creator>Hakenberg, Oliver W.</creator><creator>Heidenreich, Axel</creator><creator>Salvioni, Roberto</creator><creator>Catanzaro, Mario</creator><creator>Raggi, Daniele</creator><creator>Giannatempo, Patrizia</creator><creator>Marandino, Laura</creator><creator>Haidl, Friederike</creator><creator>Pederzoli, Filippo</creator><creator>Briganti, Alberto</creator><creator>Montorsi, Francesco</creator><creator>Chipollini, Juan</creator><creator>Azizi, Mounsif</creator><creator>De Meerleer, Gert</creator><creator>Brouwer, Oscar R.</creator><creator>Grass, G. Daniel</creator><creator>Johnstone, Peter A.</creator><creator>Albersen, Maarten</creator><creator>Spiess, Philippe E.</creator><creator>Necchi, Andrea</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3007-2756</orcidid></search><sort><creationdate>202110</creationdate><title>Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma</title><author>Bandini, Marco ; Ross, Jeffrey S. ; Zhu, Yao ; Ye, Ding-Wei ; Ornellas, Antonio A. ; Watkin, Nick ; Ayres, Benjamin A. ; Hakenberg, Oliver W. ; Heidenreich, Axel ; Salvioni, Roberto ; Catanzaro, Mario ; Raggi, Daniele ; Giannatempo, Patrizia ; Marandino, Laura ; Haidl, Friederike ; Pederzoli, Filippo ; Briganti, Alberto ; Montorsi, Francesco ; Chipollini, Juan ; Azizi, Mounsif ; De Meerleer, Gert ; Brouwer, Oscar R. ; Grass, G. Daniel ; Johnstone, Peter A. ; Albersen, Maarten ; Spiess, Philippe E. ; Necchi, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-1353a94e0634d2fa7a26dee7bf8178d4d0cf93f3a0921d588c8ad50575d6462a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adjuvant radiotherapy</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Comprehensive genomic profiling</topic><topic>Human papillomavirus infection</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Male</topic><topic>Papillomavirus Infections - complications</topic><topic>Penile cancer</topic><topic>Penile Neoplasms - radiotherapy</topic><topic>Penile Neoplasms - surgery</topic><topic>Retrospective Studies</topic><topic>Squamous-cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bandini, Marco</creatorcontrib><creatorcontrib>Ross, Jeffrey S.</creatorcontrib><creatorcontrib>Zhu, Yao</creatorcontrib><creatorcontrib>Ye, Ding-Wei</creatorcontrib><creatorcontrib>Ornellas, Antonio A.</creatorcontrib><creatorcontrib>Watkin, Nick</creatorcontrib><creatorcontrib>Ayres, Benjamin A.</creatorcontrib><creatorcontrib>Hakenberg, Oliver W.</creatorcontrib><creatorcontrib>Heidenreich, Axel</creatorcontrib><creatorcontrib>Salvioni, Roberto</creatorcontrib><creatorcontrib>Catanzaro, Mario</creatorcontrib><creatorcontrib>Raggi, Daniele</creatorcontrib><creatorcontrib>Giannatempo, Patrizia</creatorcontrib><creatorcontrib>Marandino, Laura</creatorcontrib><creatorcontrib>Haidl, Friederike</creatorcontrib><creatorcontrib>Pederzoli, Filippo</creatorcontrib><creatorcontrib>Briganti, Alberto</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Chipollini, Juan</creatorcontrib><creatorcontrib>Azizi, Mounsif</creatorcontrib><creatorcontrib>De Meerleer, Gert</creatorcontrib><creatorcontrib>Brouwer, Oscar R.</creatorcontrib><creatorcontrib>Grass, G. Daniel</creatorcontrib><creatorcontrib>Johnstone, Peter A.</creatorcontrib><creatorcontrib>Albersen, Maarten</creatorcontrib><creatorcontrib>Spiess, Philippe E.</creatorcontrib><creatorcontrib>Necchi, Andrea</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bandini, Marco</au><au>Ross, Jeffrey S.</au><au>Zhu, Yao</au><au>Ye, Ding-Wei</au><au>Ornellas, Antonio A.</au><au>Watkin, Nick</au><au>Ayres, Benjamin A.</au><au>Hakenberg, Oliver W.</au><au>Heidenreich, Axel</au><au>Salvioni, Roberto</au><au>Catanzaro, Mario</au><au>Raggi, Daniele</au><au>Giannatempo, Patrizia</au><au>Marandino, Laura</au><au>Haidl, Friederike</au><au>Pederzoli, Filippo</au><au>Briganti, Alberto</au><au>Montorsi, Francesco</au><au>Chipollini, Juan</au><au>Azizi, Mounsif</au><au>De Meerleer, Gert</au><au>Brouwer, Oscar R.</au><au>Grass, G. Daniel</au><au>Johnstone, Peter A.</au><au>Albersen, Maarten</au><au>Spiess, Philippe E.</au><au>Necchi, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma</atitle><jtitle>European urology oncology</jtitle><addtitle>Eur Urol Oncol</addtitle><date>2021-10</date><risdate>2021</risdate><volume>4</volume><issue>5</issue><spage>802</spage><epage>810</epage><pages>802-810</pages><issn>2588-9311</issn><eissn>2588-9311</eissn><abstract>Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node–involved penile squamous-cell carcinoma (PSCC) are lacking. To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinical information. ILND, with or without chemotherapy or RT for involved lymph nodes. Kaplan-Meier and restricted mean survival time (RMST) analyses for overall survival (OS) were performed for all patients and after propensity score-matching (PSM; n = 136), for which patient age, histology, type of penile surgical procedure, pathological tumor and nodal stage, ILND laterality, pelvic LND, and perioperative treatment were taken into account when assessing differences between HPV+ and HPV– patients. Finally, we looked at genomic alterations in PSCC using data from the Foundation Medicine database (n = 199) to characterize HPV+ PSCC. Patients with HPV+ PSCC (n = 86; 17%) had lower clinical N stage (p &lt; 0.001) and inguinal lymph node metastasis density (p &lt; 0.001). Perioperative RT was delivered in 49 patients (9.7%), with the vast majority receiving adjuvant RT (n = 40). HPV+ patients had similar median OS (p = 0.1) but longer RMST than HPV– patients at different time points. Nevertheless, HPV+ patients treated with perioperative RT exhibited longer median OS (p = 0.015) and longer RMST compared to HPV– patients. In the PSM cohorts, HPV+ status remained significantly associated with longer OS after RT. The HPV– PSCC group had a higher frequency of TP53 mutations compared to HPV+ PSCC (75% vs 15%; p &lt; 0.001). The results are limited by the retrospective nature of the data. Perioperative RT was more effective in the HPV+ PSCC subgroup. Reasons for the enhanced radiosensitivity may be related to the lack of TP53 mutations. We analyzed data from a large multicenter database for patients with penile cancer who had received inguinal lymph node dissection, with or without chemotherapy or radiotherapy. We found that for tumors positive for human papillomavirus (HPV), use of radiotherapy resulted in prolonged survival compared to HPV-negative tumors. On the basis of these results we are inspired to design studies on the use of radiotherapy in HPV-selected patients. We analyzed the association between human papillomavirus (HPV) infection and perioperative treatment outcomes for patients with penile squamous-cell carcinoma undergoing inguinal lymph node dissection. HPV was associated with greater benefit from perioperative radiotherapy of involved lymph nodes. A Foundation Medicine database analysis of genomic alterations in penile cancers revealed fewer TP53 and CDKN2A mutations for HPV+ than for HPV– tumors, which may in part explain their radiosensitivity.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33199252</pmid><doi>10.1016/j.euo.2020.10.011</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3007-2756</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2588-9311
ispartof European urology oncology, 2021-10, Vol.4 (5), p.802-810
issn 2588-9311
2588-9311
language eng
recordid cdi_proquest_miscellaneous_2461401167
source MEDLINE; Alma/SFX Local Collection
subjects Adjuvant radiotherapy
Carcinoma, Squamous Cell - radiotherapy
Carcinoma, Squamous Cell - surgery
Comprehensive genomic profiling
Human papillomavirus infection
Humans
Lymph Node Excision
Male
Papillomavirus Infections - complications
Penile cancer
Penile Neoplasms - radiotherapy
Penile Neoplasms - surgery
Retrospective Studies
Squamous-cell carcinoma
title Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20Between%20Human%20Papillomavirus%20Infection%20and%20Outcome%20of%20Perioperative%20Nodal%20Radiotherapy%20for%20Penile%20Carcinoma&rft.jtitle=European%20urology%20oncology&rft.au=Bandini,%20Marco&rft.date=2021-10&rft.volume=4&rft.issue=5&rft.spage=802&rft.epage=810&rft.pages=802-810&rft.issn=2588-9311&rft.eissn=2588-9311&rft_id=info:doi/10.1016/j.euo.2020.10.011&rft_dat=%3Cproquest_cross%3E2461401167%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2461401167&rft_id=info:pmid/33199252&rft_els_id=S2588931120301760&rfr_iscdi=true